Last reviewed · How we verify

NCT07334678: TROCO-HAF

TROPIS Versus Coring Out Fistulectomy in High Anal Fistula

Recruiting now NA Last updated 16 March 2026
What this trial tests

NA trial testing Transanal opening of intersphincteric space (TROPIS) in High Anal Fistula in 64 participants. Currently enrolling.

Timeline
26 November 2025
Primary endpoint
1 June 2026
1 June 2026

Quick facts

Lead sponsorCairo University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment64
Start date26 November 2025
Primary completion1 June 2026
Estimated completion1 June 2026
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

18 and older, any sex, with High Anal Fistula. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

High anal fistulas represent a surgical challenge due to high recurrence rates and risk of postoperative fecal incontinence. Several sphincter-preserving techniques have been developed to address these issues. Coring Out fistulectomy is a traditional sphincter-saving approach, while Transanal Opening of the Intersphincteric Space (TROPIS) is a recently introduced technique with promising outcomes. This randomized clinical trial aims to compare the efficacy, safety, and patient outcomes of TROPIS versus coring out fistulectomy in the management of high complex anal fistulas.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for High Anal Fistula

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07334678.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing